Exome Asset Management’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-693,300	Closed	-$1.23M	–	73
2023 Q4	$1.23M	Buy	+693,300	New	+$1.23M	1.21%	32